Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts

Journal of Clinical Investigation

Volumn 92, Issue 2, 1993, Pages 549-558

  Lemström, Karl B ^a   Bruning, Johan H ^b   Bruggeman, Cathrien A ^b   Lautenschlager, Irmeli T ^a   Häyry, Pekka J ^a  

^a Transplantation Laboratory ^*  (Finland)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Chronic rejection; Cytomegalovirus; Heart; Transplantation

Indexed keywords

EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN C; THYMIDINE; TRITIUM; VIRUS ANTIGEN;

ALLOGRAFT; ANIMAL MODEL; ANIMAL TISSUE; AORTA GRAFT; ARTERIOSCLEROSIS; ARTICLE; ATHEROGENESIS; AUTORADIOGRAPHY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INBRED STRAIN; INTIMA; NONHUMAN; PRIORITY JOURNAL; RAT; TUNICA MEDIA; VASCULAR SMOOTH MUSCLE; VIRUS INFECTION;

ANIMAL; ANTIGENS, VIRAL; AORTA, THORACIC; CELL DIVISION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; LIVER; MUSCLE, SMOOTH, VASCULAR; PLAQUE ASSAY; RATS; RATS, INBRED STRAINS; RATS, INBRED WF; SALIVARY GLANDS; SPLEEN; SUPPORT, NON-U.S. GOV'T; TRANSPLANTATION, HETEROTOPIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 0027291379     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI116622     Document Type: Article

References (52)

1. Kaye, M. P. 1992. The registry of The International Society for Heart and Lung Transplantation: Ninth Official Report 1992. J. Heart Lung Transplant. 11:599-606.
2. Barnart, G. R., E. A. Pascoe, A. C. Mills, S. Szentpetery, D. M. Eich, T. Mohanakumar, A. Hastillo, J. A. Thompson, M. L. Hess, and R. R. Lower. 1989. Accelerated coronary arteriosclerosis in cardiac transplant recipients. Transplant. Rev. 1:31-46.
3. Billingham, M. E. 1992. Histopathology of graft coronary disease. J. Heart Lung Transplant. 11:S38-S44.
4. Gao, S. Z., E. L. Alderman, J. S. Schroeder, J. F. Silverman, and S. A. Hunt. 1988. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J. Am. Coll. Cardiol. 12:334-340.
5. Olivari, M. T., D. C. Homans, R. F. Wilson, S. H. Kubo, and W. S. Ring. 1989. Coronary artery disease in cardiac transplant patients receiving triple-drug immunosuppressive therapy. Circulation. 80:S. III:111-115.
6. Johnson, D. E., E. L. Alderman, J. S. Schroeder, S. Z. Gao, S. Hunt, W. M. Decampli, E. Stinson, and M. Billingham. 1991. Transplant coronary artery disease: histopathologic correlations with angiographic morphology. J. Am. Coll. Cardiol. 17:449-457.
7. Taylor, D. O., H. M. Ibrahim, D. R. Tolman, and M. L. Hess. 1991. Accelerated coronary atherosclerosis in cardiac transplantation. Transplant. Rev. 5:165-174.
8. Hosenpud, J. D., G. D. Shipley, and C. R. Wagner. 1992. Cardiac allograft vasculopathy: current concepts, recent developments, and future directions. J. Heart Lung Transplant. 11:9-23.
9. Stovin, P. G. I., L. Sharples, J. A. Hutter, J. Wallwork, and T. A. H. English. 1991. Some prognostic factors for the development of transplant-related coronary artery disease in human cardiac allografts. J. Heart Lung Transplant. 10:38-44.
10. Sharples, L. D., N. Caine, P. Mullins, J. P. Scott, E. Solis, T. A. H. English, S. R. Large, P. M. Schofield, and J. Wallwork. 1991. Risk factor analysis for the major hazards following heart transplantation - rejection, infection, and coronary occlusive disease. Transplantation. 51:244-252.
11. Dummer, J. S., L. T. White, M. Ho, B. P. Griffith, R. L. Hardesty, and H. T. Bahnson. 1985. Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine. J. Infect. Dis. 152:1182-1191.
12. Grattan, M. T., C. E. Moreno-Cabral, V. A. Starnes, P. E. Oyer, E. B. Stinson, and N. E. Shumway. 1989. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA (J. Am. Med. Assoc.). 261:3561-3566.
13. Loebe, M., S. Schüler, Z. Ortwin, H. Warnecke, E. Fleck, and R. Hetzer. 1990. Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J. Heart Transplant. 9:707-711.
14. McDonald, K., T. S. Rector, E. A. Braunlin, S. H. Kubo, and M. T. Olivari. 1989. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am. J. Cardiol. 64:359-362.
15. Hruban, R. H., T.-C. Wu, W. E. Beschorner, D. E. Cameron, R. F. Ambinder, W. A. Baumgartner, G. M. Hutchins, and B. A. Reitz. 1990. Cytomegalo-virus nucleic acids in allografted hearts. Hum. Pathol. 21:981-983.
16. Fabricant, C. G., J. Fabricant, M. M. Litrenta, and C. R. Mimick. 1978. Virus-induced atherosclerosis. J. Exp. Med. 148:335-340.
17. Hendrix, M. G. R., M. M. M. Salimans, C. P. A. van Boven, and C. A. Bruggeman. 1990. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am. J. Pathol. 136:23-28.
18. Hendrix, M. G. R., P. H. J. Dormans, P. Kitslaar, F. Bosman, and C. A. Bruggeman. 1989. The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and non-atherosclerotics patients. Am. J. Pathol. 134:1151-1157.
19. Melnick, J. L., G. R. Dreesman, C. H. McCollum, B. L. Petrie, J. Burek, and M. E. DeBakey. 1983. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet. II:644-647.
20. Span, A. H. M., G. Grauls, F. Bosman, C. P. A. van Boven, and C. A. Bruggeman. 1992. Cytomegalovirus infection induces vascular injury in the rat. Atherosclerosis. 93:41-52.
21. Mennander, A., S. Tiisala, J. Halttunen, S. Yilmaz, T. Paavonen, and P. Häyry. 1991. Chronic rejection in rat aortic allografts: an experimental model for transplant arteriosclerosis. Arterioscler. Thromb. 11:671 -680.
22. Bruggeman, C. A., H. Meijer, P. H. J. Dormans, W. M. H. Debie, G. E. L. M. Grauls, and C. P. A. van Boven. 1982. Isolation of a cytomegalovinis-like agent from wild rats. Arch. Virol. 73:231-241.
23. Bruggeman, C. A., W. M. H. Debie, G. Grauls, G. Majoor, and C. P. A. van Boven. 1983. Infection of laboratory rats with a new cytomegalo-like virus. Arch. Virol. 76:188-199.
24. Arvin, A. M. 1985. Cytomegaloviruses. In Laboratory Diagnosis of Viral Infections. E. H. Lennette, editor. Marcel Dekker, Inc., New York. 506 pp.
25. Wentworth, B., and L. French. 1970. Plaque assay of CMV strains of human origin. Proc. Soc. Exp. Biol. Med 135:253-258.
26. Stals, F. S., F. Bosman, C. P. A. van Boven, and C. A. Bruggeman. 1990. An animal model for therapeutic intervention studies of CMV infection in the immunocompromised host. Arch. Virol. 114:91-107.
27. Bruning, J. H., W. H. M. Debie, P. H. J. Dormans, H. Meyer, and C. A. Bruggeman. 1987. The development and characterization of monoclonal antibodies against rat cytomegalovirus induced antigens. Arch. Virol. 94:55-70.
28. Aherne, W. A., and M. S. Dunnill. 1980. Morphometry. Edward Arnold, London. 170 pp.
29. Pipkin, F. B. 1984. Medical Statistics Made Easy. Churchill Livingstone, Edinburgh. 138 pp.
30. Armitage, P., and G. Berry. 1986. Further analysis of straight-line data. In Statistical Methods in Medical Research. Blackwell Scientific Publications, Oxford, UK. 559 pp. 2nd edition.
31. Montgomery, D., and E. Peck. 1982. Introduction to Linear Regression Analysis. John Wiley & Sons, Inc., New York. 504 pp.
32. Bruggeman, C. A., H. Meijer, F. Bosman, and C. P. A. van Boven. 1985. Biology of rat cytomegalovirus infection. Intervirology. 24:1-9.
33. Koskinen, P. K., L. A. Krogerus, M. S. Nieminen, S. P. Mattila, P. J. Häyry, and I. T. Lautenschlager. 1993. Quantitation of cytomegalovirus infection associated histological findings in endomyocardial biopsies of heart allografts. J. Heart Lung Transplant. In press.
34. Smiley, M. L., E.-C. Mar, and E.-S. Huang. 1988. Cytomegalovirus infection and viral-induced transformation of human endothelial cells. J. Med Virol. 25:213-226.
35. Friedman, H. M., E. J. Macarak, R. R. MacGregor, J. Wolfe, and N. A. Kefalides. 1981. Virus infection of endothelial cells. J. Infect. Dis. 143:266-273.
36. Span, A. H. M., P. M. Frederik, G. Grauls, C. P. A. van Boven, and C. A. Bruggeman. 1993. CMV induced vascular injury: an electronmicroscopic study in the rat. Atherosclerosis. In press.
37. Tumilowicz, J. J., M. E. Gawlik, P. P. Bowell, and J. J. Trentin. 1985. Replication of cytomegalovirus in human arterial smooth muscle cells. J. Virol. 56:839-845.
38. Hajjar, D. P. 1991. Viral pathogenesis of atherosclerosis: impact of molecular mimicry and viral genes. Am. J. Pathol. 139:1195-1211.
39. Melnick, J. L., E. Adam, and M. E. DeBakey. 1990. Possible role of cytomegalovirus in atherogenesis. JAMA (J. Am. Med. Assoc.). 263:2204-2207.
40. Benditt, E. P., T. Barrett, and J. K. Dougall. 1983. Viruses in the etiology of atherosclerosis. Proc. Natl. Acad. Sci. USA. 80:6386-6389.
41. Häyry, P., A. Mennander, A. Räisänen-Sokolowski, J. Ustinov, K. Lemström, P. Aho, S. Yilmaz, I. Lautenschlager, and T. Paavonen. 1993. Pathophysiology of vascular wall changes in chronic allograft rejection. Transplant. Rev. 7:1-20.
42. Shellam, G. R., J. E. Allen, J. M. Papadimitroiou, and G. J. Bancroft. 1981. Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc Natl. Acad. Sci. USA. 78:5104-5108.
43. Reddehase, M. J., G. M. Keil, and U. H. Koszinowski. 1984. The cytolytic T lymphocyte response to the murine cytomegalovirus. I. Distinct maturation stages of cytolytic T lymphocytes constitute the cellular immune response during acute infection of mice with the murine cytomegalovirus. J. Immunol. 132:482-489.
44. Reddehase, M. J., G. M. Keil, and Koszinowski. 1984. The cytolytic T lymphocyte response to the murine cytomegalovirus. II. Detection of virus replication stage-specific antigen by separate populations of in vivo active cytolytic T lymphocyte precursors. Eur. J. Immunol. 14:56-61.
45. Keller, R. R., J. N. Peitchel, J. N. Goldman, and M. Goldman. 1976. An IgG-Fc receptor induced in cytomegalovirus-infected human fibroblasts. J. Immunol. 116:772-777.
46. MacGregor, R. R., H. M. Friedman, E. J. Macarak, and N. A. Kefalides. 1980. Virus infection of endothelial cells increases granulocyte adherence. J. Clin. Invest. 65:1469-1477.
47. Iwamoto, G. K., M. M. Monick, B. D. Clark, P. E. Auron, M. F. Stinski. and G. W. Hunninghake. 1990. Modulation of interleukin 1β gene expression by the immediate early genes of human cytomegalovirus. J. Clin. Invest. 85:1853-1857.
48. Fujinami, R. S., J. A. Nelson, L. Walker, and M. B. Oldstone. 1988. Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR β chain: a means for graft rejection and immunosuppression. J. Virol. 62:100-105.
49. Beck, S., and B. G, Barrell. 1988. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature (Lond.). 331:269-272.
50. Ross, R. 1986. The pathogenesis of atherosclerosis - an update. N. Engl. J. Med. 314:488-500.
51. Hayflick, L. 1965. The limited lifetime of human diploid cell strains. Exp. Cell. Res. 37:614-636.
52. Ross, R., T. N. Wight, E. Strandness, and B. Thiele. 1984. Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am. J Pathol. 114:79-93.